Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
Categories: News

Chinook Therapeutics to Present at the Jefferies Virtual Healthcare Conference

Company to Discuss Pipeline of Precision Medicines for Kidney Diseases, Led by Phase 3 Program Atrasentan

VANCOUVER, British Columbia & SEATTLE–(BUSINESS WIRE)–Chinook Therapeutics, Inc. (“Chinook”), a privately held clinical-stage biotechnology company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Eric Dobmeier, President and Chief Executive Officer, will present an overview of the company and its pipeline at the Jefferies Virtual Healthcare Conference at 3:30 p.m. EDT on Wednesday, June 3, 2020.

To access the live webcast and subsequent archived recording of this presentation, please visit the News section of Chinook’s website at www.chinooktx.com. The archived webcast will remain available for replay on Chinook’s website for 90 days.

About Chinook Therapeutics

Chinook Therapeutics, Inc. is a clinical-stage biotechnology company developing precision medicines for kidney diseases. The company’s pipeline is focused on rare, severe chronic kidney disorders with opportunities for well defined and streamlined clinical pathways. Chinook’s lead program is atrasentan, an investigational endothelin receptor antagonist in development for the treatment of primary glomerular diseases. The company is also advancing a 2021 IND candidate for an undisclosed ultra orphan kidney disease and research programs for polycystic kidney disease. Chinook seeks to build its pipeline by leveraging insights in kidney single cell RNA sequencing, human-derived organoids and new translational models, to discover and develop therapeutics with mechanisms of action against key kidney disease pathways. Chinook is backed by leading healthcare investors, Versant Ventures, Apple Tree Partners, and Samsara BioCapital, and is based in Vancouver, BC and Seattle, WA. For more information visit www.chinooktx.com.

Contacts

Ian Stone

Canale Communications

(619) 849-5388

ian@canalecomm.com

Staff

Recent Posts

Best Crypto Roth IRA Company in the US Announced (2026 Update)

IRAEmpire has released a new and updated ranking for the best crypto Roth IRA Companies…

13 hours ago

The Mortgage Lenders Expands Nationwide Hybrid Mortgage Platform to Support 2026 Home Financing

New platform integrates broker and direct lending channels to streamline mortgage processes for borrowers. IRVINE,…

13 hours ago

Electronic Caregiver Introduces Hybrid Home Care – A Scalable Model Unlocking Millions of New Clients and Higher Margins

Electronic Caregiver is proud to sponsor the Synergy Home Care Annual Franchise Meeting LAS CRUCES,…

13 hours ago

Notification of Relevant Change to Significant Shareholder

(NYSE AMERICAN:CMCL)(AIM:CMCL)(VFEX:CMCL) SAINT HELIER, JE / ACCESS Newswire / March 27, 2026 / Caledonia Mining…

13 hours ago

“Rise” Selected as NASA Artemis II Moon Mascot

A second grader's plushie is going to the Moon! ORLANDO, FL / ACCESS Newswire /…

13 hours ago